Home

Digital twins are a virtual replica of physical objects that help businesses improve efficiency and reduce costs through simulated testing. While this method of testing has been in use for several decades, the rapid rise and adoption of IoT has led to it being considered as a tool for the future across several different industries, including healthcare.


Digitising R&D of medical devices has many benefits, including but not limited to the optimising of material design and engineering for improved performance and reliability, reducing the number of necessary benchtop tests to be performed or the number of clinical trials, and accelerating a medical device's regulatory approval process.


Authoritative agencies, such as the FDA, have routinely advised medical device manufacturers to adopt similar simulation models to help speed up when their new products and therapies can be brought to market.


This webinar will discuss and share global successful use cases covering different diagnostic equipment, highlighting how digital twins can be employed to achieve innovative and better performing products, as well as the need for a more robust product development process to be developed.


How Digital Twins Are Accelerating MedTech

Date: Tuesday, 23rd June 2020

Time: 10am to 11am (GMT+8)


Lock in your spot for this webinar now. Login details will be shared via email with those who have registered for the event, closer to the event date.

Jun 23, 2020

10:00 AM - 11:00 AMGMT+8

Speakers

  • Kristian Debus (Vice President & Silicon Valley Office Director of Thornton Tomasetti)

    Kristian Debus

    Vice President & Silicon Valley Office Director of Thornton Tomasetti

    Read Bio
  • Viriginia Chan (Head of Digital Transformation, Medical Devices Industry, APAC at Siemens Digital Industries Software)

    Viriginia Chan

    Head of Digital Transformation, Medical Devices Industry, APAC at Siemens Digital Industries Software

    Read Bio
  • Julianna Yeung (Associate Director, Head of Health Economics & Outcomes, Reimbursement & Value Strategy at Fresenius Medical  Care)

    Julianna Yeung

    Associate Director, Head of Health Economics & Outcomes, Reimbursement & Value Strategy at Fresenius Medical Care

    Read Bio
Menu